Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Bjarni ÞjóðleifssonKatrín Davíðsdóttir
Úlfur Agnarsson
Arndís Theodórs
Aðalbjörg Gunnarsdóttir
Elva Möller
Auður Jónsdóttir
Guðmundur Sigþórsson
Matthías Kjeld
Ingvar Bjarnason
Issue Date
2002-06-01
Metadata
Show full item recordOther Titles
Effect of Pentavac and MMR vaccination on the intestineCitation
Læknablaðið 2002, 88(6):491-94Abstract
Objective: The safety of infant vaccination has been questioned in recent years. In particular it has been suggested that the measles, mumps and rubella (MMR) vaccination leads to brain damage manifesting as autism consequent to the development of an "enterocolitis" in the immediate post-vaccination period. Aim: To assess if MMR vaccination is associated with sub-clinical intestinal inflammation which is central to the autistic "enterocolitis" theory. The study was not designed to test directly the association of autism to MMR vaccination. Material and methods: We studied 109/20 infants, before and two and four weeks after immunization with Pentavac and MMR vaccines, for the presence of intestinal inflammation (faecal calprotectin). Results: Neither vaccination was associated with any significant increase in faecal calprotectin concentrations. Conclusions: The failure of the MMR vaccination to cause an intestinal inflammatory response provides evidence against the proposed gut-brain interaction that is central to the autistic "enterocolitis" hypothesis.ilgangur: Að meta hvort MMR-bólusetning (measles, mumps and rubella) valdi þarmabólgu hjá íslenskum börnum. Rannsóknin var ekki hönnuð til að svara spurningunni hvort MMR-bólusetning valdi einhverfu. Aðferðir: Rannsökuð voru 109/20 börn fyrir bólusetningu og tveim, fjórum og 12-18 vikum eftir bólusetningu með Pentavac- og MMR-bóluefnum. Athugað var hvort merki væri um þarmabólgu með því að mæla kalprotectín í hægðasýni. Niðurstöður: Hvorugt bóluefnið var tengt nokkurri marktækri breytingu á þéttni kalprotectíns í hægðum og kom ekkert fram sem benti til þarmabólgu. Ályktun: Þar sem þessi rannsókn hefur sýnt að MMR-bólusetningin tengist ekki þarmabólgu þá mælir það gegn tilgátunni um að MMR tengist einhverfu í gegnum bólgu í þörmum.
Description
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenAdditional Links
http://www.laeknabladid.isCollections
Related articles
- Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine.
- Authors: Thjodleifsson B, Davídsdóttir K, Agnarsson U, Sigthórsson G, Kjeld M, Bjarnason I
- Issue date: 2002 Dec
- Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
- Authors: Mrozek-Budzyn D, Kiełtyka A, Majewska R
- Issue date: 2010 May
- A population-based study of measles, mumps, and rubella vaccination and autism.
- Authors: Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M
- Issue date: 2002 Nov 7
- Booster immune response in children 6-7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection.
- Authors: Díaz-Ortega JL, Bennett JV, Castañeda-Desales D, Quintanilla DM, Martínez D, de Castro JF
- Issue date: 2014 Jun 17
- Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
- Authors: Yadav S, Thukral R, Chakarvarti A
- Issue date: 2003 Nov